Skip to main content

The Future of Generic Drugs and Strategies for Commercial Success

The Future of Generic Drugs and Strategies for Commercial Success” discusses trends in the global generic drugs market, and the evolving business strategies being adopted and leveraged by generic drug companies around the world. Publisher conducted an extensive and targeted industry survey of experts from top global generic drug companies, to gather opinions on the trends and future commercial prospects of the generic drugs market. The findings from the survey and results from extensive data analysis and secondary research efforts have been triangulated with GBI’s own analytical views to provide an objective assessment that is comprehensive in outlook.
The generic drugs market has seen rapid expansion for more than 30 years, and consistently achieves higher annual growth rates than the overall pharmaceutical market. The increase in generic drug activity can be primarily attributed to the promise of significant revenues from blockbuster drugs nearing patent expiry. In the US – the largest generic drugs market by revenue – the number of generic drug approvals hit a record high in 2015, due to a new program that aimed to speed up approvals. There has also recently been a surge in the number of industry-transforming mergers and acquisitions, with companies looking to consolidate their position in this highly lucrative market.
The results of latest industry survey provide insightful analyses from different expert panels, including R&D and commercial, and highlight trends observed in key geographical markets. The survey examined key commercial issues and recent developments in the generic drugs market, such as the reasons behind the surge in mergers and acquisitions, and the likely effects on market dynamics. It covered important factors currently driving or restraining the market, prospects for key therapy areas expected to exhibit significant levels of genericization in the coming years, and the most promising emerging markets for generic companies in terms of revenue potential. Additionally, the survey examined common business strategies and regulations being leveraged by global generic drug companies for market expansion.
The report covers key small molecule drugs whose patents will expire in the coming years, providing an in-depth assessment of potential generic competition, expected launch dates and the overall impact on global branded revenues to 2021. The top global generic drug companies by revenue are also examined, including financial performance and recent activity within the market.
This new report adds to our unique portfolio of trusted industry analyses, which enable our clients to assess the most promising commercial areas in the market and identify key business opportunities.
Report Scope
  • What is the current value of the generic drugs market, and how will market dynamics change in the coming years?
  • Will the US continue to dominate the market?
  • Which therapy areas will witness the highest level of genericization in the next five years?
Drivers and restraints in the generics industry:
  • What are the most important factors promoting generic drug usage at a global level?
  • What are the most important factors hindering or delaying generic drug approvals?
  • Will governments worldwide continue their efforts to promote generic drug usage?
  • How will global demographic trends impact demand for generic drugs?
  • Which emerging economies are the most promising for generic drugs companies?
  • Are generic drugs still negatively perceived?
  • How are pricing pressures and rising costs affecting generic drug manufacturers?
Generic drugs pipeline for top small molecule drugs in the market:
  • What will be the revenue impact for key small molecule drugs whose patents expire in the near future?
  • What are the key patent expiry dates for these small molecules and what level of generic competition should they expect?
Strategies for commercial success:
  • What are the most popular strategies or regulations being adopted and leveraged by generic drug manufacturers?
  • What governmental policies are significantly influencing generic drug usage?
  • What will be the impact of compulsory licenses in emerging markets?
Mergers and acquisitions in the global generic drugs market:
  • What are the most important factors contributing to the surge in M&A activity in the generic drugs market?
  • How will market dynamics be affected by continued consolidation in the generic drugs market?
  • What have been the most important transactions in the generic drugs industry in recent years?
  • Top global generic drugs companies:
  • How have top generic drugs companies performed in recent years?
  • What are the prospects for top generic drugs companies?
Reasons to buy
This report will allow you to -
Gain insightful analyses and understanding of market dynamics: This report comprehensively describes and assesses the most important factors driving and restraining the generic drugs market. It assesses pertinent commercial and regulatory aspects of the industry by combining survey results with proprietary in-house expertise and extensive secondary research efforts.
Assess the generic drugs pipeline for top small molecule drugs in the market: Our study provides prospects for these drugs beyond their patent expiries, including potential generic competition, expected launch dates and revenue forecasts to 2021.
Evaluate the strategies used by companies to promote generic drug usage: This report provides insights regarding the various commercial strategies being adopted and leveraged by generic drug companies to promote their therapies.
Understand government policies and strategies to promote generic drug usage: This report assesses current strategies and regulations implemented by governments in key geographic markets to promote generic drug usage.
Gain insight on mergers and acquisitions in the global generic drugs market: This report describes industry-transforming mergers and acquisitions that have occurred in recent years, the reasons behind the recent surge in these types of transactions, and their likely impact on market dynamics.
About ReportsWeb:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us:
Call: +1-646-491-9876
Email: sales@reportsweb.com

Comments

  1. Involve a rundown of all the liquor rehab focuses in your neighborhood. You can discover this data on the web, and you might need to utilize a correlation site which will detail and rundown various offices by various standards, for instance separation to the inside or cost. Choose which rehab focus offers the best program, improving the odds of your adored one remaining calm.
    inspirational quote for recovery
    recovery inspirational quotes

    ReplyDelete
  2. Choosing a liquor or drug rehab foundation isn't an ordinary undertaking and can be truly extreme. Habit is a new however fragile issue that is hard to deal with the correct way regardless of the amount you need to support yourself or an individual you love. It is essential to align yourself with a decent and calm family member or companion that you trust and go around and look at a couple of offices. You will at that point see which options are accessible for you so you can pick the liquor or drug rehab program that is best for you.
    drug rehab center florida

    ReplyDelete

Post a Comment

Popular posts from this blog

Wearable Medical Device Market Exploring Future Growth 2019-2025 and Key Players – Abbott Laboratories(USA) , MC10(USA) , Medtronic (Corventis)(USA) , Insulet(USA) , Gentag(USA)

ReportsWeb.com has announced the addition of the “Global Wearable Medical Device Market Research Report” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. An exclusive Wearable Medical Device Market research report has been fabricated through the in depth analysis of the market dynamics across five regions such as North America, Europe, South America, Asia-Pacific, Middle East and Africa. The segmentation of the market by type, application, and region was done based on the thorough market analysis and validation through extensive primary inputs from industry experts, key opinion leaders of companies, and stakeholders) and secondary research (global/regional associations, trade journals, technical white papers, company’s website, annual report SEC filing, and paid databases). Further, the market has been estimated by utilizing various research methodologies and internal statistical model. M

Service Delivery Automation Market Driving Factors, 2016-2022 Market Analysis, Investment Feasibility and Trends | Key Players – Ibm , Uipath , Ipsoft, Blueprism, Xerox

Service delivery automation (sda) industry was valued at $620 million in 2014, and is expected to reach $6,752 million by 2022, growing at a cagr of 25.7% from 2016 to 2022. Sda is also termed as robotic process automation as well as intelligent automation depending upon the area of usage. It is a technology that has replaced array of human actions or work and automates the flow of business processes that earlier used to be done manually. Automation is already embedded in software systems to a great extent; for instance, we can see the customer information is linked across financial as well as procurement functions. However, mostly it is assumed as a part of the normal feature and functionality of a system, and generally not considered as automation, but simply termed as a more powerful system(s). Sda is mostly referred to automation in it infrastructure and application management services, robotic process automation as well as business process automation. The sda market is segment

Cable Management Market Ongoing Trends and Recent Developments | Key Players – Cooper Industries (Eaton), Legrand, Prysmian S.p.A., Atkore International Holdings

Cable Management Market Report, published by Publisher, forecasts that the global market is expected to garner $25.1 billion by 2022, registering a CAGR of 12.4% during the period 2016-2022. North America is the dominant market and is expected to be the leading contributor in global revenue, owing to the high adoption of cable management solutions in various end user industries in the region. Converged infrastructure and high density servers result in abundance of power, thereby demanding higher adoption of cable management systems for efficient power and energy management. In addition, ongoing developments in commercial constructions and infrastructure in the Asia-Pacific region are likely to facilitate the growth of the market. The key players profiled in this report are: Cooper Industries (Eaton), Legrand, Prysmian S.p.A., Atkore International Holdings Inc., Leviton Manufacturing Co., Inc., Panduit, Thomas & Betts (ABB group), Chatsworth Products, Inc., Nexans, Schneider Ele